150 related articles for article (PubMed ID: 30686578)
1. MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy.
Kohnken R; Mishra A
J Invest Dermatol; 2019 Mar; 139(3):528-534. PubMed ID: 30686578
[TBL] [Abstract][Full Text] [Related]
2. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Kohnken R; Wen J; Mundy-Bosse B; McConnell K; Keiter A; Grinshpun L; Hartlage A; Yano M; McNeil B; Chakravarti N; William B; Bradner JE; Caligiuri MA; Porcu P; Mishra A
Blood; 2018 Feb; 131(7):771-781. PubMed ID: 29180399
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.
Kohnken R; McNeil B; Wen J; McConnell K; Grinshpun L; Keiter A; Chen L; William B; Porcu P; Mishra A
J Invest Dermatol; 2019 Sep; 139(9):1966-1974.e3. PubMed ID: 30876800
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
5. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.
Dusílková N; Bašová P; Polívka J; Kodet O; Kulvait V; Pešta M; Trněný M; Stopka T
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036928
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma.
Adeeb M; Therachiyil L; Moton S; Buddenkotte J; Alam MA; Uddin S; Steinhoff M; Ahmad A
Int Rev Cell Mol Biol; 2023; 380():149-171. PubMed ID: 37657857
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.
Lai P; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):34-51. PubMed ID: 33628583
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
[TBL] [Abstract][Full Text] [Related]
10. Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
Mishra A; La Perle K; Kwiatkowski S; Sullivan LA; Sams GH; Johns J; Curphey DP; Wen J; McConnell K; Qi J; Wong H; Russo G; Zhang J; Marcucci G; Bradner JE; Porcu P; Caligiuri MA
Cancer Discov; 2016 Sep; 6(9):986-1005. PubMed ID: 27422033
[TBL] [Abstract][Full Text] [Related]
11. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma.
Shen X; Wang B; Li K; Wang L; Zhao X; Xue F; Shi R; Zheng J
J Invest Dermatol; 2018 Sep; 138(9):2024-2032. PubMed ID: 29559342
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
15. What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract][Full Text] [Related]
16. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
[TBL] [Abstract][Full Text] [Related]
17. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
18. Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.
Kopp KL; Ralfkiaer U; Nielsen BS; Gniadecki R; Woetmann A; Ødum N; Ralfkiaer E
APMIS; 2013 Nov; 121(11):1020-4. PubMed ID: 24033365
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapy and dermatologic disease: moving beyond CTCL.
Mervis JS; McGee JS
J Dermatolog Treat; 2019 Feb; 30(1):68-73. PubMed ID: 29726727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
